Niagen Bioscience
NAGE
52 hedge funds and large institutions have $15.3M invested in Niagen Bioscience in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 8 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 9
25% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 8
17% more capital invested
Capital invested by funds: $13M → $15.3M (+$2.21M)
12.16% more ownership
Funds ownership: 0% → 12.16% (+12%)
4% more funds holding
Funds holding: 50 → 52 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$622K |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$322K |
| 3 |
Morgan Stanley
New York
|
+$212K |
| 4 |
AWA
Arete Wealth Advisors
Chicago,
Illinois
|
+$177K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$155K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Spark Investment Management
New York
|
-$404K |
| 2 |
SCM
Silver Capital Management
New York
|
-$352K |
| 3 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
-$172K |
| 4 |
SG Americas Securities
New York
|
-$85K |
| 5 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$72.9K |
NAGE Hedge Fund Activity: Q4 2016 in Review
52 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q4 2016, worth a combined $15.3M — up 17% from $13M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new NAGE positions and 8 closed out — a net gain of 2 holders — while 15 added to existing stakes and 9 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $622K. The largest seller was Spark Investment Management, exiting entirely with an estimated $404K sold.
- 52 institutional investors held Niagen Bioscience (NAGE) as of Q4 2016, up from 50 in Q3 2016.
- Funds reported $15.3M of Niagen Bioscience stock for Q4 2016, up 17% quarter-over-quarter.
- 10 funds opened new Niagen Bioscience positions in Q4 2016 and 8 closed out, a net change of +2 holders.
- The largest Niagen Bioscience buyer in Q4 2016 was Millennium Management, an estimated $622K added.
- The largest Niagen Bioscience seller in Q4 2016 was Spark Investment Management, an estimated $404K sold.
Based on aggregated 13F filings for Q4 2016.